2026 International Congress Archives - Page 151 of 208

Tablet-Based Quantitative Evaluation of Finger Movement in Essential Tremor: A Visual-Motor Task Study

P. Tang, Y. Liu (Xi'an, China)
Taekwondo Training with External Focus of Attention as a Complex Motor Intervention in Parkinson’s Disease: A Pilot Study

B. Kim, M. Torbitt, J. Lombardi, A. Deblois (Syracuse, USA)
Tailoring Exergame-Based Training to Parkinson’s Disease: Qualitative insights from Clinicians, Relatives, and Technology Experts

N. Baraznenok, P. Manser, B. Leavy, A. Wallin, E. Franzén (Huddinge, Sweden)
Tardive Dystonia Case Ceries and Choreathethosis Case Report Secondary to Cocaine Use From a Specialized Movement Disorder Center in Santiago, Chile.

M. Niedbalski, M. Canals, F. Urbina, V. Besa (Santiago, Chile)
Targeted IncobotulinumtoxinA Injections into the Muscle of Riolan: A Novel Rescue Strategy for Refractory Apraxia of Lid Opening in Neurodegenerative Disorders

I. Miliukhina (Saint-Petersburg, Russian Federation)
Targeted Repeat-Expansion Screening Highlights Unmet Genomic Needs in Genetically Naive Ataxia: A Ukrainian Single-Centre Pilot Study

S. Bandrivska, L. Mederos, N. Dominik, C. Correa, F. Magrinelli, H. Houlden, T. Slobodin (London, United Kingdom)
Targeting c-Abl/Drp1-Dependent Mitochondrial Fission: Neuroprotective Effects of Berberine Chloride in Parkinson’s Disease Models

D. Khatri (Chandwaji, Jaipur, India)
Targeting the Immunoproteasome PSMB8: A dual strategy to enhance α-synuclein clearance and mitigate CD8+ T-Cell neurotoxicity in Parkinson’s Disease

HD. Nguyen, HBT. Tran, TT. Nguyen, IH. Kwak, YJ. Kim, H. Ma, HJ. Kim, YE. Kim (Anyang, Republic of Korea)
Targeting the NLRP3 Inflammasome by PD180970 Based on Differential Susceptibility to MPTP

S. Choudhury, M. Srinivas Bharath, R. Yadav, P. Alladi (Bangalore, India)
Task-Dependent Modulation of Reflexive and Voluntary Saccades in Parkinson Disease and Multiple System Atrophy

H. Kim, Y. Bae, J. Yun (Seoul, Republic of Korea)
Telemedicine in Parkinson’s Disease Management: Lessons from Resource-Limited Settings Like Nepal

AYU. Chandra, AVI. Chandra, SUD. Acharya (Kathmandu, Nepal)
Telerehabilitation Versus Conventional Therapy in Parkinson’s Disease: Evidence from Randomized Controlled Trials

A. Fornari Caprara, J. Pitton Rissardo, J. Patino, A. Mcgarry, I. Walker (Camden, USA)
Temporal Interference Stimulation of Dentate Nucleus Suppressed Essential Tremor

S. Zhang, W. Ren, D. Li, M. Zhou, Z. Zhou, X. Song, T. Ma, T. Xu, Z. Gao, Y. Wu (Shanghai, China)
Temporal Ordering of Biomarker Abnormality Events Leading to Cognitive Impairment in Parkinson’s Disease: A Disease Event-Based Model Analysis of the PPMI Cohort

A. Negida (Richmond, USA)
Temporal Prediction and Multisensory Integration in Musician’s Dystonia

H. Klein, J. Doll-Lee, E. Passarotto, T. Oku, S. Furuya, E. Altenmüller, A. Lee (Hannover, Germany)
Temporally Patterned Deep Brain Stimulation Improves Gait Metrics and Freezing of Gait in Parkinson’s Disease

S. Song, H. Azgomi, A. Sayaseng, R. Ramesh, H. Bokil, S. Niketeghad, D. Wang (San Francisco, USA)
Testing the body vs brain-first hypothesis in early PD: a cross-sectional study

A. Querejeta-Coma, H. Canfield, L. Yupanqui-Guerra, L. Santos-Sánchez-de-Las-Matas, M. Sánchez-Boyero, E. Escario, M. Pintor-Zamora, CM. Ordás-Bandera (Móstoles, Spain)
Thalamic Hub Dysregulation in FCMTE1: Multimodal MRI and Gene-Imaging Evidence

JX. Li, HT. Wang, B. Wang, W. Luo (Hangzhou, China)
THD (Tyrosine Hydroxylase Deficiency) in a 39-Year-Old Woman with Early-Onset Dystonia

T. Le (Dallas, USA)
The “Sequestration” hypothesis: Longitudinal systemic priming and CNS infiltration of Neutrophil Extracellular Traps in Parkinson’s Disease

HD. Nguyen, S. Lee, H. Ma, YJ. Kim, HJ. Kim, YE. Kim (Anyang, Republic of Korea)
The “Guarda” (Tower) Drawing Test: A Novel Bedside Tool to Quantify Bradykinesia in Parkinson’s Disease

S. Celi Aguilar, F. Ramos, F. Echeverria, T. Arakaki, S. Rodriguez Quiroga, N. Garretto (Buenos Aires, Argentina)
The 360° Turn Test as a Single and Dual Task in people with Parkinson’s disease and cognitively unimpaired controls

M. Lindh-Rengifo, S. Fors, S. Palmqvist, E. Stomrud, N. Mattsson-Carlgren, M. Nilsson (Malmö, Sweden)
The Allosteric Activator of Lysosomal Glucocerebrosidase VQ-101 Demonstrates Robust Evidence of Target and Pathway Engagement in People with Parkinson’s Disease: Results from a 6-Month Open-Label Extension Study

M. Facheris, J. Valk, I. Koopmans, K. Hunt, M. Hagey, O. Siddiqui, P. Kremer, J. Sullivan, D. Ysselstein (Chicago, USA)
The Alternating Finger Tapping Test Poorly Predicts Real-World Daily Activity Performance in Parkinson’s Disease

P. Kaewsom, K. Horaruengdecha, P. Panyakaew (Bangkok, Thailand)
The Anxiolytic Effect of Cannabidiol and Tetrahydrocannabinol in a Reserpine Model of Parkinson’s Disease in Mice

H. Tanko, T. Muhammad, A-S. Isa (Zaria, Nigeria)
The Association between Antiepileptic Drug Use, Epilepsy and the Risk of Parkinson’s Disease: A Systematic Review and Meta-analysis

RG. Mohamed, O. Yousef (Mansoura, Egypt)
The Association Between Gastrointestinal Dysfunction and Psychological Health in Individuals with Parkinson’s Disease

M. Messing, N. Meier (Irvine, USA)
The association between Parkinson’s Disease and Diabetes Mellitus.

SJ. Foo, CS. Tan, H. Ng, K. Tay, S. Neo, W. Li, W. Au, Z. Xu, L. Tan (Singapore, Singapore)
The association of low back pain-related disability with functional mobility among individuals with Parkinson disease in Sri Lanka.

YS. Thakshila, HHN. Kalyani (Colombo, Sri Lanka)
The Barcelona PSP Registry Therapeutic Education Program: a Longitudinal Study

A. Camara, J. Herrero, M. Carrasco, M. Baixauli, S. Pelaez, C. Torregrossa, I. Quinoa, C. Painous, M. Fernandez, I. Zaro, Y. Compta (Barcelona, Spain)
The Burden of Cognitive Impairment in People with Parkinson’s across Outpatients and Prevalent Patients in Coastal Kenya: A Transforming Parkinson’s Care in Africa (TraPCAf) Study

R. Morton, S. Mwamba, D. Nyabuto, J. Nambafu, S. Kariuki, D. Sokhi, S. Ahmed, Y. Okkaoglu, C. Dotchin, C. Newton, N. Fothergill-Misbah, N. Okubadejo, R. Walker (Newcastle Upon Tyne, United Kingdom)
The Care Assessment Need Score Underestimates 90-Day Mortality in Veterans with Parkinson’s Disease

A. Bossart, A. Hiller, G. Scott (Portland, USA)
The Cats-and-Dogs Test Predicts Cognitive Impairment in Parkinson’s Disease in a Diverse Population

KC. Dey, D. Mair, T. Zannat, A. Zirra, E. Camboe, E. Bhadra, ABS. Haque, R. Weil, D. Gallagher, C. Budu, T. Haque, S. Hussain-Ali, N. Mukadam, A. Habib, CR. Marshall, AJ. Noyce, S. Waters (Dhaka, Bangladesh, Bangladesh)
The Challenges for Diagnosis of Movement Disorders in Ukraine

Y. Trufanov, N. Khanenko, M. Trishchynska, Y. Tarasenko, T. Voronova-Smolyannikova, A. Galusha, N. Pavliuk, A. Ovchynnykova, R. Sulik, V. Sereda, L. Zviahina, A. Babirad, V. Dubynetska, K. Bakum, V. Yevdokymov, A. Mykhailenko, K. Moisieieva, Z. Tyzhuk, N. Vintoniv-Trushyk, Y. Compta (Kyiv, Ukraine)
The Clinical and Biological effects of a Whole Foods and Plant-Based Dietary Intervention in Parkinson’s Disease

B. Boon, S. Meles, B. Bloem, T. van Laar, E. Postma (Groningen, Netherlands)
The Clinical and Neuropathological Factors Associated with Brain Atrophy in CSF1R-RD.

L. Milanowski, D. Liskey, A. Strongosky, D. Dickson, Z. Wszolek (Warsaw, Poland)
The Clinical Profile and Management outcomes of Early-Onset Dystonia in a South African Population

E. Assey, V. Mabasa, D. Magazi (Garankuwa, Gauteng, South Africa)
The Correlation Between Serum Uric Acid Levels And The Severity Of Parkinson’s Disease

D. Prihananti, E. Pasmanasari (Semarang, Indonesia)
The Diagnostic Value of Dopaminergic-Glucose United PET Imaging in Parkinson’s disease

XY. Li, JY. Lu, FT. Liu, CT. Zuo, JW. Wang (Shanghai, China)
The Dual Functional Organization of the Substantia Nigra in Parkinson’s Disease

M. Passaretti, D. Vereb, B. Zufiria-Gerbolés, M. Mijalkov, M. Veronese, J B. Pereira (Stockholm, Sweden)
The Effect of Depression on the Cognitive Phenotype in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia.

C. Hurtado-González, J. Ayala-Rico, S. Ospina Otalvaro, P. Gutiérrez-Lenis, A. Cubides-Munévar, A. Botero-Carvajal, J. Centeno-Arispe, D. Reyes-Torres, K. Ponce-Gil, J. Cedeño-Buitrago, L. Ortega-Bolaños (Cali, Colombia)
The Effect of Levodopa on Calpain Activity in Patients with Parkinson’s Disease

Z. Muruzheva, M. Karpenko (St. Petersburg, Russian Federation)
The Effect of LRRK2 and GBA1 Mutations on Survival in Early- and Late-onset Parkinson’s Disease

R. Rubin, RN. Alcalay, N. Omer, O. Goldstein, M. Gana Weisz, A. Mirelman, A. Thaler (Tel Aviv, Israel)
The Effect of Scapular Dysfunction on Dynamic Balance in Patients with Parkinson’s Disease

G. Polat, A. Fil, Y. Salci, Aİ. Yalcin, S. Topuz, E. Turgut, G. Yalcin Cakmaklı, B. Elibol (Ankara, Turkey)
The Effects of Bright Light Therapy on Improving Sleep Disorders in Parkinson’s Disease

WY. Xie, JM. Duan, WX. Duan, Y. Chen, F. Wang, Y. Shen, CF. Liu (Suzhou, China)
The Effects of War on Patients with Parkinson’s Disease

F. Hojjatipour, M. Salari, M. Etemadifar, K. Rezaei (Tehran, Islamic Republic of Iran)
The Emerging Landscape of Genotype-Stratified Clinical Trials in Parkinson’s Disease and Atypical Parkinsonian Disorders

YY. Beh, SY. Lim, AM. Abdul Sahak, L. Lange, K. Brolin, A. Noyce, M. Nalls, A. Singleton, H. Morris, AH. Tan (Kuala Lumpur, Malaysia)
The enteric footprint of de novo parkinson’s disease cohort: constipation, inflammation, and nulisa biomarker profiling.

S. Enriquez Calzada, M. Miret Milian, L. Melgarejo, M. Arrué, A. López, S. Belmonte, M. Martinez-Vicente, J. Hernandez-Vara, A. Laguna (Barcelona, Spain)
The epidemiological study of multiple system atrophy beginning in Hokkaido, Japan 2014-2026

M. Matsushima, K. Sakushima, N. Nishimoto, J. Sawada, T. Matsuoka, H. Uesugi, N. Minami, K. Sako, A. Takei, S. Hisahara, Y. Kanatani, A. Tamakoshi, N. Sato, I. Yabe (Sapporo, Japan)
The Evolutionary Pathway of Cognitive Impairment in Parkinson’s Disease: A SuStaIn Study

A. Huang, X. Xue, Z. Wu, S. Liu, E. Xu, P. Chan (Beijing, China)
The Feasibility and Safety of Rehabilitation Program in Patients with Multiple System Atrophy

GY. Lee, S. Cha, S. Jo, J. Lee, M. Choi, SJ. Chung, SH. Lee (Seoul, Republic of Korea)
The Global Parkinsons Genetics Program: Expanding the Diversity of Neurological Disorder Data – 2026 Update

GP2. Global_parkinsons Genetics_program (Bethesda, USA)
The GLP-1 Agonist Paradox in Parkinson’s Disease: A Comparative Analysis of Lixisenatide and Exenatide Phase III Trial Outcomes and Neuroprotective Mechanisms

F. Al-Zaidi (Almaty, Kazakhstan)
The Green Parkinson’s Belt: An Ecological Study of Agricultural Regions Linked to Increased Disease Burden in Mexico

F. Luna-Rangel, B. Gonzalez-Bedolla, S. Robles-Bernal, E. Santiago-Delacruz, D. Rebolledo-Garcia (Monterrey, Mexico)
The Historical Role of Sex and Gender in the History of Access to Movement Disorder Care: A Literature Review

S. Corrick, J. Miyasaki, F. Ba, S. Joza (Edmonton, Canada)
The Impact of Delaying Subcutaneous Device-Aided Therapy for Patients with Advanced Parkinson’s Disease

R. Wiggins, J. Lee, T. Boodhna, O. Yip, J. Homola, L. Pronk, R. van Den Puttelaar, J. Aldred (Charlotte, USA)
The Impact of Demographic Factors on Skull Density Ratios in a Hawaii Cohort

K. Thai, F. Gao, M. Morita, R. Shuman, M. Faouzi, E. Krening, M. Bruno (Honolulu, USA)
The Impact of Dopamine-Induced Impulse Control Disorders on Quality of Life in Young-Onset Parkinson’s Disease

S. Pokhriyal, A. Gupta (Delhi, India)
The Impact of Insomnia and Sleep Fragmentation on Quality of Life and Neuropsychiatric Outcomes in Restless Legs Syndrome

A. Kumar, P. Mishra (Delhi, India)
The Impact of Insurance on Delivery of Huntington’s Care at an HDSA Center of Excellence

D. Okine, L. Shammas, M. Tobar, P. Perez, A. Mendizabal (Los Angeles, USA)
The Impact of the Edmond J. Safra Nurse Educator Program at the Parkinson’s Foundation on Nursing Education and Parkinson’s Care

A. Li Wong (New York, USA)
The Influence of Glymphatic System Impairment on Cognitive Decline in Parkinson’s Disease

Q. Zhang, FT. Liu, J. Wang (Shanghai, China)
The influence of Parkinson’s disease duration on perceived quality of inpatient care

L. Eickholt, C. Kruse, W. Aamodt (Philadelphia, USA)
The influence of probable rapid eye movement sleep behavior disorder on PD-related motor and non-motor symptoms and multiple functional outcomes among Chinese community-dwelling elderly population

C. Han, P. Wang, J. Ma, P. Chan (Beijing, China)
The Landscape of Movement Disorders in Mitochondrial Aminoacyl t-RNA Synthetase Disorders: A Case Series

SRC. Roychowdhury, HA. Alfaris, SY. Yoganathan, AM. Menetrey, LMV. M. Vogt, RA. Alayed, LLM. Leblanc-Millar, DC. Cordeiro, LA. Aljouda, CG. Gorodetsky (Toronto, Canada)
The Lentiform Fork Sign: Acute Parkinsonism in a Dialysis Patient with Metformin Misuse

J. Haddad Labello, B. Souza Telho, J. Cavalcanti, R. Bernhart Carra, J. Bezerra Parmera (Sao Paulo, Brazil)
The Lewy Body Dementia Domain Rating Scale (LBD-DRS): Patient and Care Partner Perspectives

E. Matar, B. Boeve, D. Galasko, J. Kane, F. Rodriguez-Porcel, A. Schrag, S. Sikkes, J. Taylor (Sydney, Australia)
The Lived Experience of Parkinson’s Disease in the Philippines: Challenges, Cultural Constructs, and Caregiving Impacts

FM. Lawas, GS. Saranza, JH. Hernani (Cebu, Philippines)
The Long-Term Efficacy of Globus Pallidus Deep Brain Stimulation in Tardive Dystonia and Dyskinesia

G. Je, S. Miocinovic, S. Factor, S. Radmard (Atlanta, USA)
The Nature of autonomic dysfunction and its relationship with motor symptoms in Drug-Naive Parkinson’s Disease Patients: Korean Cohort Data

YS. Hwang, J. Park, JM. Seok (Jeonju, Republic of Korea)
The Non-Motor and Extra-Cerebellar Motor Spectrum of Adult-Onset Genetic and Sporadic Cerebellar Ataxias

E. Woo, D. Abo Alsamh, V. Bruno, V. Karnik, S. Furtado (Calgary, Canada)
The ORCHESTRA Study Year 2: Practical Experiences With Foslevodopa/Foscarbidopa Treatment in Advanced Parkinson’s Disease in a Real-World Setting

T. Warneck, A. Der Plas, P. Schwingenschuh, A. Johansson, M. Simu, M. O’Meara, M. Li, T. Hancko, L. Bergmann, T. Musacchio, M. Südmeyer (Osnabrück, Germany)
The OxQUIP At-Home Study: Protocol and Preliminary Findings

N. Conway, C. Sotirakis, A. D'Souza, M. Gibbs, J. Huxley, B. Cooley, M. Dockendorf, J. Ren, O. Patil, S. Lee, J. Fitzgerald, C. Antoniades (University of Oxford, United Kingdom)
The Parkinson’s Clinical Cohorts Collaborative (PC3) – A Novel Research Database for Parkinson’s Disease Research

A. Kuri, S. Waters, L. Smith, A. Thomson, R. Lawson, A. Macleod, M. Murray, M. Hu, A. Noyce (London, United Kingdom)
The Parkinson’s Impact Project: A Multimodal Longitudinal Study of Disease Development and Progression at the 23andMe Research Institute

M. Kmiecik, L. Norcliffe-Kaufmann, W. Xu, C. Weldon, V. Tran, A. Guan, M. Mcintyre, S. Aslibekyan (Palo Alto, USA)
The PD Diary by MDS: Development and Early Usability Testing of a Patient-Centered Digital Tool for Parkinson’s Disease

P. Rábano-Suárez, M. Monje, J. Vizcarra, S. Paul, S. Avión, M. Morse, M. Skorvanek, M. Tosin, R. Fuller, T. Turner, M. Dekker, D. Hall, K. Bergmann, J. Cedarbaum, W. Maetzler, A. Espay, P. Martínez-Martín, G. Stebbins, T. Mestre, A. Sánchez-Ferro (Madrid, Spain)
The Potential of Mobile Applications to Enhance Self-Management in Parkinson’s Disease: A Systematic Review

F. Kanellos, S. Kontaxis, S. Kontogiannis, A. Ntanis, N. Kostikis, G. Rigas (Ioannina, Greece)
The predictive value of the 18F-FDG PET-derived Parkinson’s disease Related Pattern for neurodegenerative disease progression in isolated REM Sleep Behavior Disorder

A. Dortmond, S. Lövdal, G. Carli, K. Leenders, K. Reetz, S. Schawohl, D. Arnaldi, B. Orso, S. Morbelli, A. Janzen, W. Oertel, D. Perani, L. Ferini-Strambi, A. Galbiati, C. Liguori, A. Chiaravalloti, M. Carpi, J. Lee, R. Kim, S. Meles (Ann Arbor, USA)
The Prevalence of Parkinson’s Disease in Kilifi County, Kenya: A ‘Transforming Parkinson’s Care in Africa’ (TraPCAf) study

R. Morton, S. Mwamba, D. Nyabuto, S. Kariuki, A. Nyaguara, J. Nambafu, M. Atieno, D. Sokhi, M. Cham, S. Urasa, N. Okubadejo, O. Ojo, Y. Okkaoglu, C. Dotchin, N. Fothergill-Misbah, C. Newton, R. Walker (Newcastle Upon Tyne, United Kingdom)
The Protective role of Blood brain barrier-Vagal Interface in Parkinsonian pathology in mice

J. Ahn, J. Heo, M. Lee, C. Pyo, J. Jeong, Y. Kim, W. Chung, E. Oh (Daejeon, Republic of Korea)
The Registry for Sleep and Circadian Health Quality in Parkinson’s Disease (ReSCQu-PD)

J. Thomas, J. Cohen (Jacksonville, USA)
The Relationship Between Neurobehavioral Profile and Cognitive Phenotype in Patients with Idiopathic Parkinson’s Disease Without Dementia.

C. Hurtado-González, J. Ayala-Rico, S. Ospina Otalvaro, P. Gutiérrez-Lenis, A. Cubides-Munévar, A. Botero-Carvajal, J. Centeno-Arispe, D. Reyes-Torres, K. Ponce-Gil, J. Cedeño-Buitrago, L. Ortega-Bolaños (Cali, Colombia)
The Relationship Between Substantia Nigra Hyperchogenicity and Clinical Features and Disease Progression in Parkinson’s Disease Patients

WJ. Hu, HH. Luan (Yantai, China)
The Role of Electrophysiology in Preventing Diagnostic Misclassification of a Craniocervical Dystonia

A. Talaugon*, A. Young*, S. Jaradeh, N. Samudra, B. Razavi, P. Kahali (Palo Alto, USA)
The Role of Nurses in the Management of Parkinson’s Disease : A Single-Center Study From Tunisia

R. Zouari, N. Ghanmi, A. Sghaier, S. Ben Sassi (Tunis, Tunisia)
The Shape Of Sequence Effect In Parkinson’s Disease

A. Grandolfo, L. Angelini, M. de Riggi, D. Birreci, S. Aloisio, G. Paparella, A. Cannavacciuolo, M. Bologna (Rome, Italy)
The Spectrum of Praxis Impairments in Patients with Parkinson’s Disease

Z. Zalyalova, S. Munasipova, A. Volkova (Kazan, Russian Federation)
The Sweet Smell of ON: Phantosmia During Motor Fluctuations After Initiation of Foslevodopa/Foscarbidopa Infusion Therapy

S. Giri Ravindran, K. Afshin, E. Noyes (Saskatoon, Canada)
The Syn-D Study: Detection of Longitudinal Changes in Cutaneous Phosphorylated Alpha-Synuclein in Mild Cognitive Impairment

R. Freeman, T. Levine, J. Parent, S. Marcotte, B. Bellaire, M. Duval, C. Gibbons (Boston, USA)
The Syn-Q Study: Quantification of phosphorylated alpha-synuclein in patients with Parkinson’s disease and REM sleep behavior disorder

R. Freeman, T. Levine, J. Parent, S. Marcotte, B. Bellaire, M. Duval, C. Gibbons (Boston, USA)
The Syn-Sleep Study: Detection of Cutaneous Phosphorylated Alpha-Synuclein in REM Sleep Behavior Disorder

T. Levine, S. Marcotte, J. Parent, B. Bellaire, M. Duval, R. Freeman, C. Gibbons (scottsdale, USA)
The Therapeutic Landscape of SSPE: A Systematic Review of Antiviral and Immunomodulatory Modalities

V. Jadhav, S. Errabelly, M. Tripathi, D. Dash, P. Mohapatra, E. Arunmozhimaran (Lucknow, India)
The Transcriptomic, Neurotransmitter, and Cell Type Signatures Underlying Pure Fatigue in Early-stage Parkinson’s Disease

Y. Xiao, S. Wang, Y. Hou, R. Ou, C. Li, W. Song, X. Shi, X. Zhu, H. Shang (Chengdu, China)
The UF Adaptive Deep Brain Stimulation Experience

A. Madamangalam, D. Vuddandam, J. Cagle, J. Wong, C. de Hemptinne (Gainesville, USA)
The Unholy Marriage Between Ogilvie Syndrome and Parkinson’s Disease

Y. Zashchypas, S. Lorenzl (Salzburg, Austria)
The Use of Digital Tools for Parkinson’s Phenotype Stratification to Improve Patients’ Selection for Advanced Therapies

T. Diven, S. Lane, K. Muhammed, L. Agley, R. Ellis, J. Pannicker, J. Osman-Farah, A. Macerollo (Liverpool, United Kingdom)
The utility of HbA1c in Predicting Neuroimaging Findings in Diabetic Striatopathy – A Systematic Review

L. D’Souza, G. Srinivasa, K. Reddy, D. T, D. Sanjaya, S. Katti, R. Agarwal, M. Singhvi (Bangalore, India)
Therapeutic effects of intermittent theta-burst stimulation on motor, non-motor symptoms and functional connectivity in de novo Parkinson’s disease

R. Rashid-López, P. Macías-García, AJ. Cruz-Gómez, FL. Sánchez-Fernández, E. Sarrias-Arrabal, F. Cano-Cano, M. García-Corrales, R. Martínez-Regueiro, M. Melcón-Martín, F. Sanmartino, R. Espinosa-Rosso, JJ. González-Rosa (Cádiz, Spain)
Therapeutic Efficacy of a Next-Generation 16-Contact Directional Deep Brain Stimulation System in Parkinson’s Disease

F. Morgante, C. Matthies, S. Vinke, R. Schuurman, V. Visser-Vandewalle, A. Gharabaghi, V. Coenen, J. Fitzgerald, D. Pedrosa, A. Kühn, C. Mertz, L. Chen, R. Shivacharan, E. Goldberg (London, United Kingdom)
Therapeutic Potential of Probiotics for Clinical Management in Parkinson’s Disease: A Systematic Review

A. Suhendro, A. Kristanto, S. Trisnawati (Denpasar, Indonesia)
Three Different Behavioral Trajectories in L-DOPA–Treated Parkinson’s Disease Patients

G. Albani, GP. Mingolla, M. Giardini, S. Corna (Veruno, Italy)
Three Years On: Outcomes of Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s disease from the Irish National DBS service

F. Ruggieri, M. Kelly, A. Gill, C. O'Keeffe, J. Inocentes, E. Reynolds, M. Garvey, N. Austin, M. Borsek, E. Pereira, T. Lynch, C. Faeron, C. Moran, R. Walsh (Dublin, Ireland)
Three-Year Results from the Largest Prospective Cohort of Directional Subthalamic Deep Brain Stimulation in Parkinson’s Disease to Date

G. Deuschl, M. Barbe, S. Paschen, A. Kühn, C. Sik Lee, J. Volkmann, J. Vesper, R. Shivacharan, E. Goldberg (Cologne, Germany)
Timing of Deep Brain Stimulation and Cognitive Trajectories in GBA1-associated Parkinson’s Disease

E. Asimakidou, M. Avenali, J. O. Aasly, M. Afshari, R. Alcalay, S. Anderson, CA. Artusi, B. Bernard, M. Bozzali, S. Bressman, G. Calandra-Buonaura, F. Cavallieri, R. Cilia, JC. Corvol, A. Cocco, RMA. de Bie, D. Ehrlich, R. Eleopra, G. Pal, EM. Valente (Cambridge, United Kingdom)
Title: Association of Neurofilament Light Chain and Peripheral Inflammatory Biomarkers with Clinical Progression in Parkinson’s Disease

D. Daminov, A. Xamidov, F. Saidvaliev (Tashkent, Uzbekistan)
TMEM106B Amyloid Fibrils in the Choroid Plexus Mediate [18F]AV-1451 Retention: Cohort-Level Imaging and Cryo-EM Evidence

Y. Fan, WB. Zhao, QY. Zhao, JY. Lu, D. Li, J. Wang (Shanghai, China)
TMEM106B Fibrils Potentiate Pathological α-Synuclein Aggregation in Parkinson’s Disease

WB. Zhao, WB. Yu, C. Liu, J. Wang, Y. Fan (Shanghai, China)
To Protect Life and Safeguard Autonomy: Ambiguous Expressions of the Will to Live

J. Braun, B. Schmitz-Luhn (Bonn, Germany)
Tongue Fasciculations in Amyotrophic Lateral Sclerosis Compared Between Electromyography and Transoral Ultrasonography

N. Iijima, Y. Hagiwara, Y. Yamano (Kawasaki City, Kanagawa Prefecture, Japan)
Tongue Shape Complexity in Cantonese Parkinsonian Speech

C. Wang, M. Wong, B. Wang (Kowloon, Hong Kong)
Too Weak to Stand, Too Stiff to Fall: Overlap Syndrome of Stiff-Person-Syndrome and Anti-HMGCR Necrotizing Myopathy. Case report.

W. Trillo Alvarez, C. Ibañez Escalante, K. Choque Pereyra, C. Pinto Torres, D. Cahuana Ibarra, A. Carpio Peña, J. Escalante Ortiz, M. Nieto Rosas, S. Meza Caceres, S. Paliza Huamani, G. Delacuba Vargas (AREQUIPA, Peru)
Topographic Heterogeneity of Dopaminergic Denervation and Iron Deposition in Functional Subregions of Nigrostriatal System in Parkinson’s Disease

YJ. Duan, XL. Liu, XJ. Dan, Y. Li, H. Zhang, HW. Qiao, W. Mao, EH. Xu, SY. Liu, P. Chan (Beijing, China)
Toward a Standardized Measure of Parkinson’s Disease Psychosis: Preliminary Inter-Rater Reliability of the MDS Parkinson’s Disease Psychosis Rating Scale (MDS-PDPRS)

M. Tosin, T. Mestre, G. Stebbins, L. Montoya-Quinchia, S. Videmsky, S. Ali, D. Aarsland, J. Goldman, T. Khoo, S. Lewis, P. Martinez-Martin, O. Ojo, J. Pagonabarraga, A. Schrag, D. Weintraub, C. Goetz (Chicago, USA)
Toward Global Best Practices for Managing Skin Complications in Subcutaneous Infusion Therapy for Parkinson’s Disease: A Nursing and Advanced Practice Perspective

C. Goas, K. Papesh, N. Bryden, J. Nguyen, C. Kyinn, E. Edwards, N. Stapleton, B. Aparante, S. Gould, E. Zinn (Henderson, USA)
Toward Objective Monitoring of Motor Fluctuations in Parkinson’s Disease: TMS-EEG Biomarkers

T. Fay-Karmon, T. Davidy, A. Suminski, A. Saar, N. Zifman, N. Fogel, S. Hassin-Baer (Ramat Gan, Israel)
Towards Biomarker-Driven Staging of Multiple System Atrophy Using Longitudinal Neurofilament Light Profiling

L. Lei, R. Lee, P. Korlipara, V. Chelban, H. Houlden (London, United Kingdom)
Towards Deep Learning for Personalized Parkinson’s Disease Tremor Segmentation and Severity Classification Using Wearable Sensors

J. Jaegerman, C. Lucasius, J. Ambrad, C. Gorodetsky (Toronto, Canada)
Towards intraoperative physiology-informed design of intermittent burst deep brain stimulation

G. Issabekov, J. Busch, M. Tuncer, J. Schikora, P. Truckenmueller, GH. Schneider, A. Kühn, L. Steiner (Berlin, Germany)
Towards the detection of troublesome dyskinesia in Parkinson’s disease using wearable sensors

M. Ruben, C. Duval (Montréal, Canada)
Toxic narratives: Farmers with Parkinson’s Disease in the foothills of Kilimanjaro

S. Urasa, R. Mwezi, M. Dekker (Moshi, United Republic of Tanzania)
TRACK-PD: Understanding Treatment Routines and Adherence in Care – Knowledge and Perspective of People Living with Parkinson’s Disease

D. Marinho, H. C Brigas, G. Harrison-Jones, J. Holenz, F. de Renzis, B. Dias (São Mamede do Coronado, Portugal)
Trancranial Sonography Reveals Striatal Neurodegeneration in the Prodromal Phase of X-linked Dystonia-Parkinsonism

M. Pauly, C. Diesta, P. Cataniag, M. Borsche, H. Hanssen, J. Ong, JQ. Oropilla, U. Walter, D. Dressler, S. Algodon, A. Westenberger, C. Klein, N. Brüggemann (Lübeck, Germany)
Trans-Spinal Theta Burst Stimulation for Axial Symptoms in Parkinson´s Disease with Deep Brain Stimulation A Randomized Clinical Trial

A. Rocha, J. Simões, S. Santos, R. Carra, J. Oliveira, G. Nunes, C. França, I. Paraguay, S. Casagrande, M. Carvalho, P. Martins, E. Barbosa, R. Cury (Salvador, Brazil)
Transcriptomic Profiling of Frataxin-Deficient Drosophila melanogaster to Identify Molecular Drivers and Pathway Disruptions in Friedreich’s Ataxia

V. Swarup, R. Yadav, A. Ahuja, P. Yadav, A. Srivastava, D. Garg (New Delhi, India)
Transcutaneous Auricular Vagus Nerve Stimulation as a Novel Therapy for Parkinson’s Disease: Meta-Analytic Evidence of Motor and Gait Effects

K. Sarhan (Mansoura, Egypt)
Transcutaneous Spinal Cord Stimulation in Hereditary Spastic Paraplegias

J. Sanderson, M. Davis, H. Farhadi, C. Moritz, F. Inanici (Seattle, USA)
Transforming Acute Parkinson’s Care: Impact of a Proactive, Specialist-led Front-Door Rapid Response Parkinson’s Service (RRPD)

N. Silva, K. Ramsay, S. Ulikova (Surron In Ashfield, United Kingdom)
Transient Hemichorea Hemiballismus From A Punctate Centrum Semiovale Corona Radiata Infarct

V. Alvarez, J. Ong (Makati City, Philippines)
Transitional Life Events in Friedreich Ataxia: Differential Age at Onset Perspectives

A. Iskandar, D. Sarwinska, T. Klockgether, S. Borel, F. Xie, E. Davies, K. Reetz, T. Klopstock, L. Schöls, S. Boesch, M. Buchholz, B. Michalowsky (Greifswald, Germany)
Translating Real-World Parkinsonian Facial Kinematics onto Diverse Digital Avatars

C. Gundler, A. Wiederhold, M. Pötter-Nerger (Hamburg, Germany)
Translational evaluation of CSF as a relevant compartment for assessing target engagement of therapeutic anti–α-syn antibodies.

M. Ramos Vega, B. Ozgur, F. Sotty, A. Jensen, K. Bjerregaard-Andersen (Copenhagen, Denmark)
Translational Target Engagement of HER-096 Demonstrates Concordant Proteostasis and Mitochondrial Modulation in Preclinical Models and Patients with Parkinson’s Disease

K. Holmström, A. Ludwig, N. Kulesskaya, A. Domanska, K. Jääskeläinen, C. Videbaek, H. Huttunen (Espoo, Finland)
Traumatic Brain Injury Exacerbates Parkinsonian Neurodegeneration Through Alpha Synuclein Dysregulation

A. Singh, R. Gupta, S. Singh, N. Gupta (Varanasi, India)
Treadmill-Based Backward Walking Training as a Rehabilitation Strategy in People with Parkinson’s Disease: A Feasibility Study

N. Kumar, M. Natarajan, C. Balasubramanian, A. Prabhu (Udupi, India)
Treatment of Bilateral Centromedian-Parafascicular (CM-Pf) Deep Brain Stimulation in a Pediatric Case of Rapid-Onset Dystonia-Parkinsonism

Y. Zhao, L. Wei, Z. Yi, Z. Wang, Y. Sun (Beijing, China)
Treatment Patterns and Time Between Therapies Among People with Parkinson’s Disease

M. Lubomski, A. Evans, R. Mackinnon, R. Rossiter, M. Falster, M. Kouhkamari, T. Suresh, A. Mikolaizak, J. Waern (St Leonards, Australia)
Treatment Patterns in Adults with Isolated Dystonia in the United States

M. Oldham, J. Kerner, S. Dasgupta, J. Imperato, J. Thornton (Cambridge, USA)
Treatment Patterns in Parkinson’s Disease in Kyrgyzstan: Evidence from a Kyrgyz PD Cohort

E. Zhunusova, S. Kyialbekova, C. Shambetova (Bishkek, Kyrgyzstan)
Treatment-Responsive Holmes Tremor in a Patient with HIV-Associated Hydrocephalus: An Experience from Tertiary Care Hospital

AC. Pratiwi, N. Raisa, B. Munir, P. Atdisuramad, SB. Rianawati (Malang, Indonesia)
Tremor and Gait Worsening in Angelman Syndrome:Phenotypic Variability in Two Adult Sisters With Possible Valproate-Related Exacerbation

L. Salinas-Yañez, J. Altamirano, D. Avecilla-Bonilla, K. Salinas-Barboza (CDMX, Mexico)
Tremor in Oromandibular Dystonia

A. Jain, S. Pandey (Faridabad, India)
Tremor on Smiling but Not Laughing: An Electrophysiological Study

Y. Tai, T. Lin (Kaohsiung, Taiwan)
Tremor-onset Parkinson’s Disease: Does Leg Tremor Portend a Poor Prognosis?

D. Diaz, K. Mazinke, A. Rajput, A. Rajput, E. Noyes (Saskatoon, Canada)
Tremorography as an objective marker of the response after MRgFUS VIM in essential tremor and Parkinson’s disease

A. Krasilnikova, K. Evdokimov, V. Ovchinnikov, A. Simonyan, V. Tyurnikov, N. Abdullina, A. Broutian, S. Illarioshkin (Moscow, Russian Federation)
Triplet repeat length determines the liquid-liquid phase separation propensity of single-dtranded DNA

HJ. Yang, JI. Choi (Incheon, Republic of Korea)
Two Voices, One Disease: Patient and Care Partner Decision Dynamics on Advanced Therapies for Parkinson’s Disease

W. Zhang, C. Jimenez Moreno, T. Tervonen, G. Al-Jassar, M. Kirchner, M. Penn, T. Machewitz, C. de Vries, A. Gabriel, C. Gøtzsche, J. Lott, A. Merriam Crespo, A. Mitchell, M. de Leon (Berlin, Germany)
Two-year Outcomes of Rapid Eye Movement Behavior Disorder Following Globus Pallidus Interna Deep Brain Stimulation for Parkinson’s Disease

J. Zuzuarregui, A. Wiltshire, A. Mahes, S. Wang, M. San Luciano (San Francisco, USA)
Two-year Outcomes of Restless Legs Syndrome Following Globus Pallidus Interna Deep Brain Stimulation for Parkinson’s Disease

J. Zuzuarregui, A. Mahes, A. Wiltshire, S. Wang, M. San Luciano (San Francisco, USA)
Type 1 Diabetes and Risk of Parkinson’s Disease: A Nationwide Nested Case–Control Study

SH. Jeong, MH. Yu, N. Hong (Yongin-si, Republic of Korea)